Weissman James B

Avg. Two Year Performance

328% Avg. Purchase Return
107% Compound
(18%) Avg. Sale Return
(8%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return5%(4%)(14%)(4%)328%
Purchase Success Rate1 of 10 of 10 of 10 of 11 of 1
Average Sale Return(4%)9%(6%)(9%)(18%)
Sale Success Rate12 of 1810 of 187 of 183 of 181 of 18
Drugs » Biotechnology

Chief Operating Officer & EVP:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--